Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SRX3207 |
Synonyms | |
Therapy Description |
SRX3207 is a dual inhibitor that targets Syk and PI3K, which potentially reduces tumor immunosuppression, increases cytotoxicity, and inhibits tumor growth (PMID: 31974273). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SRX3207 | SRX-3207|SRX 3207 | PI3K Inhibitor (Pan) 40 SYK Inhibitor 15 | SRX3207 is a dual inhibitor that targets Syk and PI3K, which potentially reduces tumor immunosuppression, increases cytotoxicity, and inhibits tumor growth (PMID: 31974273). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|